
CAS 2096989-55-6
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte.
Ticagrelor R,R,S,R-Isomer
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormel:C23H28F2N6O4SFarbe und Form:White Off-White Light Yellow SolidMolekulargewicht:522.18608(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
CAS:Formel:C23H28F2N6O4SReinheit:98%Molekulargewicht:522.5680(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
CAS:(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diolReinheit:98%ent-Ticagrelor
CAS:Formel:C23H28F2N6O4SFarbe und Form:White To Off-White SolidMolekulargewicht:522.57(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
CAS:Reinheit:98%Molekulargewicht:522.5700073ent-Ticagrelor
CAS:Kontrolliertes Produkt<p>Applications ent-Ticagrelor is the enantiomer of Ticagrelor (T437700); the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)<br></p>Formel:C23H28F2N6O4SFarbe und Form:NeatMolekulargewicht:522.57Ent-ticagrelor
CAS:Ent-ticagrelor is a chirally pure pharmaceutical compound, categorized as a P2Y12 receptor antagonist, derived synthetically. This stereoisomer exemplifies the principle of stereochemistry in drug development, focusing on molecular specificity. Its mode of action involves selective binding to the P2Y12 adenosine diphosphate (ADP) receptors on platelets. This binding effectively inhibits the ADP-mediated activation of the GPIIb/IIIa receptor complex, which is crucial for platelet aggregation and clot formation.Formel:C23H28F2N6O4SReinheit:Min. 95%Molekulargewicht:522.6 g/molTicagrelor Related Compound 34 (DP6)
CAS:Formel:C23H26F2N6O5SFarbe und Form:White To Off-White SolidMolekulargewicht:536.56Ref: 4Z-T-8149
Ausgelaufenes produkt








